Bodil Ohlsson is a professor at Lund University and consultant at Skåne University Hospital. Her choice to investigate the role of sugars and starches in IBS is linked to a geneticist’s discovery: a genetic variation that hinders the breakdown of sugars and starches in the gut is overrepresented among IBS patients.
Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug in small study
SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against